GeNeuro SA (GNRO.PA)

EUR 0.08

(6.38%)

Operating Expenses Summary of GeNeuro SA

  • GeNeuro SA's latest annual operating expenses in 2023 was 14.35 Million EUR , up 12.46% from previous year.
  • GeNeuro SA's latest quarterly operating expenses in 2023 FY was 15.2 Million EUR , up 19.12% from previous quarter.
  • GeNeuro SA reported a annual operating expenses of 12.76 Million EUR in annual operating expenses 2022, up 76.36% from previous year.
  • GeNeuro SA reported a annual operating expenses of 7.23 Million EUR in annual operating expenses 2021, down -6.06% from previous year.
  • GeNeuro SA reported a quarterly operating expenses of 15.2 Million EUR for 2023 FY, up 19.12% from previous quarter.
  • GeNeuro SA reported a quarterly operating expenses of 7.63 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of GeNeuro SA (2023 - 2013)

Historical Annual Operating Expenses of GeNeuro SA (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 14.35 Million EUR 12.46%
2022 12.76 Million EUR 76.36%
2021 7.23 Million EUR -6.06%
2020 7.7 Million EUR -19.43%
2019 9.56 Million EUR 60385.71%
2018 15.81 Thousand EUR -23.8%
2017 20.75 Thousand EUR 3.63%
2016 20.02 Thousand EUR 184.07%
2015 7049.20 EUR -99.86%
2014 5.1 Million EUR 51.37%
2013 3.37 Million EUR 0.0%

Peer Operating Expenses Comparison of GeNeuro SA

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -243.723%
ABIVAX Société Anonyme 127.37 Million EUR 88.728%
Adocia SA 15.62 Million EUR 8.137%
Aelis Farma SA 18.81 Million EUR 23.708%
Biophytis S.A. 14.33 Million EUR -0.17%
Advicenne S.A. 8.21 Million EUR -74.769%
genOway Société anonyme 16.73 Million EUR 14.225%
IntegraGen SA 5.35 Million EUR -168.235%
Medesis Pharma S.A. 1.56 Million EUR -817.65%
Neovacs S.A. 10.34 Million EUR -38.804%
NFL Biosciences SA 4.37 Million EUR -228.215%
Plant Advanced Technologies SA 2.76 Million EUR -419.28%
Quantum Genomics Société Anonyme 1.71 Million EUR -735.716%
Sensorion SA 27.05 Million EUR 46.93%
Theranexus Société Anonyme 3 Million EUR -377.782%
TME Pharma N.V. 5.49 Million EUR -161.184%
Valbiotis SA 9.86 Million EUR -45.479%
TheraVet SA 1.64 Million EUR -773.149%
Valerio Therapeutics Société anonyme 20.32 Million EUR 29.344%
argenx SE 1.34 Billion EUR 98.931%
BioSenic S.A. 7.58 Million EUR -89.335%
Celyad Oncology SA 8.49 Million EUR -69.108%
DBV Technologies S.A. 89.4 Million EUR 83.941%
Galapagos NV 327.98 Million EUR 95.623%
Genfit S.A. 54.8 Million EUR 73.802%
Hyloris Pharmaceuticals SA 17.98 Million EUR 20.18%
Innate Pharma S.A. 64.57 Million EUR 77.765%
Inventiva S.A. 120.18 Million EUR 88.054%
MaaT Pharma SA 21.59 Million EUR 33.525%
MedinCell S.A. 32.92 Million EUR 56.39%
Nanobiotix S.A. 58.92 Million EUR 75.635%
Onward Medical N.V. 20.64 Million EUR 30.456%
Oryzon Genomics S.A. 18.49 Million EUR 22.381%
OSE Immunotherapeutics SA 23.58 Million EUR 39.136%
Oxurion NV 12.21 Million EUR -17.548%
Pharming Group N.V. 204.24 Million EUR 92.971%
Poxel S.A. 28.76 Million EUR 50.088%
GenSight Biologics S.A. 32.66 Million EUR 56.04%
Transgene SA 31.23 Million EUR 54.029%
Financière de Tubize SA 114.38 Thousand EUR -12451.294%
UCB SA 2.94 Billion EUR 99.512%
Valneva SE 134.92 Million EUR 89.359%
Vivoryon Therapeutics N.V. 24.69 Million EUR 41.854%